Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Tackling cancer from the inside out: a deep dive into immune checkpoint inhibitors

In the past two decades, immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, showing promising results against various solid tumors. This study reviews recent developments in ICIs, focusing on new targets like T cell immunoreceptor with Ig and ITIM domains (TIGIT), T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3), and lymphocyte activation gene-3 (LAG-3). These targets aim to overcome resistance mechanisms limiting the effectiveness of current therapies, such as anti-PD-1 and anti-CTLA-4. By identifying and developing these new ICIs, researchers hope to improve treatment outcomes and provide new therapeutic options for cancer patients.

August 13, 2024


June 30 2025

June 29 2025

June 28 2025

June 27 2025

June 26 2025

June 25 2025

June 24 2025

June 23 2025

June 22 2025

June 21 2025

June 20 2025

June 19 2025

June 18 2025

June 17 2025

June 16 2025